|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 113, Issue 2 269-278, Copyright © 2000 by Company of Biologists
JOURNAL ARTICLES |
IR Gupta, M Macias-Silva, S Kim, X Zhou, TD Piscione, C Whiteside, JL Wrana and ND Rosenblum
Division of Nephrology, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
Bone morphogenetic protein (BMP)-2 and hepatocyte growth factor (HGF) exert antagonistic effects on renal collecting duct formation during embryogenesis. A current model proposes HGF inhibits BMP-2 signaling at the level of Smad1 in a common target cell. Here, we show that BMP-2 and HGF control collecting duct formation via parallel pathways. We examined the interactions between BMP-2 and HGF in the mIMCD-3 model of collecting duct morphogenesis. During tubule formation, HGF rescued the inhibitory effects of BMP-2 and of a constitutive active form of the BMP-2 receptor, ALK3, stably expressed in mIMCD-3 cells. To determine whether the effect of HGF occurs through known mediators which act downstream of the BMP-2/ALK3 complex, we examined the effect of HGF on BMP-2-induced Smad1 phosphorylation, Smad1/Smad4 complex formation, and Smad1 nuclear translocation. Neither HGF nor other receptor tyrosine kinase ligands (EGF, FGF-4) induced phosphorylation of endogenous Smad1 in mIMCD-3 cells or in Mv1Lu, MC3T3-E1 or P19 cells. Furthermore, none of these ligands blocked induction of the BMP-responsive promoter, Tlx2. Thus, HGF overcomes the inhibitory effects of BMP-2 on collecting duct morphogenesis without interrupting any of the known signaling events in the BMP-2 dependent Smad1 signaling pathway. We conclude that BMP-2/ALK3 and HGF function to control parallel pathways downstream of their respective cell surface receptors. Integration of these signals likely occurs at the level of transcriptional or post-transcriptional events.
This article has been cited by other articles:
|
|
 |
|
  S. Hartwig, D. Bridgewater, V. Di Giovanni, J. Cain, Y. Mishina, and N. D. Rosenblum BMP Receptor ALK3 Controls Collecting System Development J. Am. Soc. Nephrol., January 1, 2008; 19(1): 117 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Pache, C. Schafer, S. Wiesemann, E. Springer, M. Liebau, H. C. Reinhardt, C. August, H. Pavenstadt, and M. J. Bek Upregulation of Id-1 via BMP-2 receptors induces reactive oxygen species in podocytes Am J Physiol Renal Physiol, September 1, 2006; 291(3): F654 - F662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Leung-Hagesteijn, M. C. Hu, A. S. Mahendra, S. Hartwig, H. J. Klamut, N. D. Rosenblum, and G. E. Hannigan Integrin-Linked Kinase Mediates Bone Morphogenetic Protein 7-Dependent Renal Epithelial Cell Morphogenesis Mol. Cell. Biol., May 1, 2005; 25(9): 3648 - 3657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Morigi, B. Imberti, C. Zoja, D. Corna, S. Tomasoni, M. Abbate, D. Rottoli, S. Angioletti, A. Benigni, N. Perico, et al. Mesenchymal Stem Cells Are Renotropic, Helping to Repair the Kidney and Improve Function in Acute Renal Failure J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1794 - 1804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Hu, D. Wasserman, S. Hartwig, and N. D. Rosenblum p38MAPK Acts in the BMP7-dependent Stimulatory Pathway during Epithelial Cell Morphogenesis and Is Regulated by Smad1 J. Biol. Chem., March 26, 2004; 279(13): 12051 - 12059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Y. Kim, D.-H. Lee, D. K. Lee, B. C. Kim, H. T. Kim, F. S. Leach, W. M. Linehan, R. A. Morton, and S. J. Kim Decreased Expression of Bone Morphogenetic Protein (BMP) Receptor Type II Correlates with Insensitivity to BMP-6 in Human Renal Cell Carcinoma Cells Clin. Cancer Res., December 1, 2003; 9(16): 6046 - 6051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Hu, T. D. Piscione, and N. D. Rosenblum Elevated SMAD1/{beta}-catenin molecular complexes and renal medullary cystic dysplasia in ALK3 transgenic mice Development, June 15, 2003; 130(12): 2753 - 2766. [Abstract] [Full Text] [PDF]
|
|
